Skip navigation

Calls to Action

Science News

September 28, 2012

Autism Speaks is pleased to announce nearly $5 million in funding for new research on autism spectrum disorders (ASD). The grants include a Suzanne and Bob Wright Trailblazer Award to study the multi-generation effects of medications taken during pregnancy. Other research projects include:

A large clinical trial will test the safety and effectiveness of oxytocin nasal spray to improve sociability and communication in children and teens with autism. The federally funded clinical trial follows the promising results of a pilot study funded by Autism Speaks.